Assessing the Effect of Clinical Trial Evidence and Anecdote on Caregivers’ Willingness to Use Corticosteroids: A Randomized Controlled Trial
Open Access
- 13 August 2019
- journal article
- research article
- Published by SAGE Publications in Journal of Cutaneous Medicine and Surgery
- Vol. 24 (1) , 17-22
Abstract
Treatment of childhood atopic dermatitis (AD) is hindered by nonadherence, but caregiver reassurance may help overcome this hurdle. To assess caregivers’ willingness to treat childhood AD with a corticosteroid when presented with clinical trial evidence, anecdote, or both. A total of 476 caregivers were recruited through a dermatology clinic and online crowdsourcing platform. Subjects were randomized to receive clinical trial evidence, anecdote, or both, using either the term “medication” or “topical steroid.” Additional caregivers were queried about their willingness to treat with the doctor’s recommendation or without knowledge of its safety information. Responses were recorded on a 10-point Likert scale. Caregivers’ willingness to treat was higher in all information assignment groups compared to those not provided with safety information: clinical trial evidence of a “medication” (P = .003; Cohen’s d = 0.83) or “topical steroid” (P = .030; d = 0.55), anecdote of a “medication” (P < .0001; d = 1.37) or “topical steroid” (P < .0001; d = 0.85), both clinical trial evidence and anecdote of a “medication” (P < .0001; d = 1.00) or “topical steroid” (P = .000; d = 0.89), and simply the doctor’s recommendation (P < .0001; d = 0.92). Significance was corrected for multiple comparisons to 0.0018. There were no differences between caregivers of children with and without AD (P = .36). Providing anecdotal reassurance, even in the setting of reported high willingness to treat with the doctor’s recommendation, may be an effective strategy to improve caregivers’ perceptions of starting new medications.Keywords
This publication has 13 references indexed in Scilit:
- Frequency of Primary Nonadherence to Acne TreatmentJAMA Dermatology, 2015
- Optimizing outcomes for paediatric atopic dermatitisBritish Journal of Dermatology, 2014
- Potential Barriers to Adherence in Pediatric DermatologyPediatric Dermatology, 2011
- The Children's Dermatology Life Quality Index (CDLQI): initial validation and practical useBritish Journal of Dermatology, 2010
- Understanding and Improving Treatment Adherence in Pediatric PatientsSeminars in Cutaneous Medicine and Surgery, 2010
- Predictors of First-Fill Adherence for Patients With HypertensionAmerican Journal of Hypertension, 2009
- Effect of sequential applications of topical tacrolimus and topical corticosteroids in the treatment of pediatric atopic dermatitis: An open-label pilot studyJournal of the American Academy of Dermatology, 2009
- Expert consensus: time for a change in the way we advise our patients to use topical corticosteroidsBritish Journal of Dermatology, 2008
- Adherence to MedicationNew England Journal of Medicine, 2005
- Atopic dermatitisThe Lancet, 2003